Plunkett Research Online: BriaCell Therapeutics

BRIACELL THERAPEUTICS (BCT:TSX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

BriaCell Therapeutics Corp is a clinical stage immuno-oncology focused biotechnology company developing the first off the shelf personalized immunotherapy for cancer. The company's lead product candidate, Bria-IMT™, is in Phase IIa for advanced breast cancer with BriaDX™, a companion diagnostic. Pat.....



BriaCell Therapeutics
Ticker: BCT
Exchange: TSX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone:
Fax:
Address: 235-15th Street
Suite 300
3rd Floor, Bellevue Centre
West Vancouver, BC V7T 2X1 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Gadi LevinCFO
Rahoul SharanDirector
See More
BriaCell Therapeutics Corp is a clinical stage immuno-oncology focused biotechnology company developing the first off the shelf personalized immunotherapy for cancer. The company's lead product candidate, Bria-IMT™, is in Phase IIa for advanced breast cancer with BriaDX™, a companion diagnostic. Pat.....See More See More

Auditor: Davidson & Company LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: